Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06793696 · ClinicalTrials.gov registry record · NA
Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,129
- Enrollment target
NCT06793696 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,129 participants.
The verdict
NCT06793696, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,129 participants
- Enrollment target
Study Summary
This study is stage 1 of a larger study which refines and optimizes the EMBED\* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. This study does not have open enrollment. Investigators will use a Multiphase Optimization STrategy (MOST) framework study with preparation, optimization, and confirmatory phases. In the current project, optimization phase, stage1 investigators will conduct a 2x2x2 factorial trial in which they expand EMBED to include sustainable implementation strategies: nurse prompt for withdrawal assessment, and targeted clinician prompt to use the CDS along with patient resources to promote equity and motivate readiness to start treatment. Later study phases will include optimization phase, stage 2: rapid-cycle randomized testing, and evaluation phase: a randomized trial of the optimized package compared to the original EMBED and the evaluation phase in which investigators will compare the efficacy of the optimized, multicomponent CDS package to the original EMBED CDS on ED-initiation of buprenorphine rates in patients with OUD in a randomized trial. \*EMBED is a user centered, clinician facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community
Interventions
- OTHER Patient facing materials
- OTHER Nurse prompt
- OTHER Provider prompt
- OTHER EMBED
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,129 participants |
| Start Date | 2025-03-21 |
| Est. Completion | 2025-10-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06793696
The ClinicalTrials.gov registry entry for NCT06793696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Patient facing materials is the first listed.
NCT06793696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06793696 about?
NCT06793696 is a clinical study titled "Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial". This study is stage 1 of a larger study which refines and optimizes the EMBED\* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder. This study does n...
What is the current status of trial NCT06793696?
This trial is currently completed. It is a NA study. The enrollment target is 1,129 participants. The study started on 2025-03-21. Estimated completion is 2025-10-14.
What interventions are being tested in trial NCT06793696?
The interventions under investigation include: Patient facing materials (OTHER), Nurse prompt (OTHER), Provider prompt (OTHER), EMBED (OTHER).
Who is sponsoring clinical trial NCT06793696?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.